Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 294

1.

Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice.

Dimitriadis GK, Nasiri-Ansari N, Agrogiannis G, Kostakis ID, Randeva MS, Nikiteas N, Patel VH, Kaltsas G, Papavassiliou AG, Randeva HS, Kassi E.

Mol Cell Endocrinol. 2019 Jun 10;494:110487. doi: 10.1016/j.mce.2019.110487. [Epub ahead of print]

PMID:
31195080
2.

Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms.

Chatzellis E, Angelousi A, Daskalakis K, Tsoli M, Alexandraki KI, Wachuła E, Meirovitz A, Maimon O, Grozinsky-Glasberg S, Gross D, Kos-Kudła B, Koumarianou A, Kaltsas G.

Neuroendocrinology. 2019 Jun 3. doi: 10.1159/000500135. [Epub ahead of print]

PMID:
31167197
3.

Malignant Pheochromocytomas/Paragangliomas and Ectopic Hormonal Secretion: A Case Series and Review of the Literature.

Angelousi A, Peppa M, Chrisoulidou A, Alexandraki K, Berthon A, Faucz FR, Kassi E, Kaltsas G.

Cancers (Basel). 2019 May 24;11(5). pii: E724. doi: 10.3390/cancers11050724. Review.

4.

Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells.

Bikas A, Jensen K, Patel A, Costello J, Kaltsas G, Hoperia V, Wartofsky L, Burman K, Vasko V.

Int J Oncol. 2019 Jul;55(1):7-20. doi: 10.3892/ijo.2019.4802. Epub 2019 May 16.

PMID:
31115496
5.

Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasms.

Daskalakis K, Tsoli M, Angelousi A, Kassi E, Alexandraki K, Kolomodi D, Kaltsas G, Koumarianou A.

Endocr Connect. 2019 Apr 1. pii: EC-19-0134.R1. doi: 10.1530/EC-19-0134. [Epub ahead of print]

6.

Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary.

Alexandraki KI, Tsoli M, Kyriakopoulos G, Angelousi A, Nikolopoulos G, Kolomodi D, Kaltsas GA.

Minerva Endocrinol. 2019 Apr 15. doi: 10.23736/S0391-1977.19.03012-8. [Epub ahead of print]

PMID:
30991795
7.

Clock genes and cancer development in particular in endocrine tissues.

Angelousi A, Kassi E, Nasiri-Ansari N, Randeva HS, Kaltsas GA, Chrousos GP.

Endocr Relat Cancer. 2019 Apr 1. pii: ERC-19-0094.R1. doi: 10.1530/ERC-19-0094. [Epub ahead of print] Review.

PMID:
30959483
8.

Current best practice in the management of neuroendocrine tumors.

Tsoli M, Chatzellis E, Koumarianou A, Kolomodi D, Kaltsas G.

Ther Adv Endocrinol Metab. 2018 Oct 31;10:2042018818804698. doi: 10.1177/2042018818804698. eCollection 2019. Review.

9.

Nonneuroendocrine Neoplasms of the Pituitary Region.

Kaltsas GA, Kolomodi D, Randeva H, Grossman A.

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3108-3123. doi: 10.1210/jc.2018-01871.

PMID:
30779850
10.

Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance.

Daskalakis K, Tsoli M, Srirajaskanthan R, Chatzellis E, Alexandraki K, Angelousi A, Pizanias M, Randeva H, Kaltsas G, Weickert MO.

Neuroendocrinology. 2019;108(4):308-316. doi: 10.1159/000497183. Epub 2019 Jan 23.

PMID:
30673674
11.

The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.

Alexandraki KI, Pizanias M, Uri I, Thomas D, Page T, Kolomodi D, Low CS, Adesanya O, Tsoli M, Gross DJ, Randeva H, Srirajaskanthan R, Grozinsky-Glasberg S, Kaltsas G, Weickert MO.

Endocrine. 2019 Jun;64(3):690-701. doi: 10.1007/s12020-019-01838-8. Epub 2019 Jan 11.

PMID:
30635793
12.

A Bioelectronic System to Measure the Glycolytic Metabolism of Activated CD4+ T Cells.

Crowe SM, Kintzios S, Kaltsas G, Palmer CS.

Biosensors (Basel). 2019 Jan 9;9(1). pii: E10. doi: 10.3390/bios9010010.

13.

Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms.

Jensen RT, Bodei L, Capdevila J, Couvelard A, Falconi M, Glasberg S, Kloppel G, Lamberts S, Peeters M, Rindi G, Rinke A, Rothmund M, Sundin A, Welin S, Fazio N; The ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):26-36. doi: 10.1159/000494258. Epub 2018 Oct 3.

PMID:
30282083
14.

Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms.

Daskalakis K, Chatzelis E, Tsoli M, Papadopoulou-Marketou N, Dimitriadis GK, Tsolakis AV, Kaltsas G.

Endocrine. 2019 May;64(2):384-392. doi: 10.1007/s12020-018-1773-3. Epub 2018 Oct 2.

15.

Iodine intake and chronic autoimmune thyroiditis: a comparative study between coastal and mainland regions in Greece.

Giassa Τ, Mamali I, Gaki Ε, Kaltsas G, Kouraklis G, Markou ΚΒ, Karatzas T.

Hormones (Athens). 2018 Dec;17(4):565-571. doi: 10.1007/s42000-018-0057-x. Epub 2018 Sep 28.

PMID:
30267376
16.

Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.

Baudin E, Hayes AR, Scoazec JY, Filosso PL, Lim E, Kaltsas G, Frilling A, Chen J, Kos-Kudła B, Gorbunova V, Wiedenmann B, Nieveen van Dijkum E, Ćwikła JB, Falkerby J, Valle JW, Kulke MH, Caplin ME; ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):7-17. doi: 10.1159/000493980. Epub 2018 Sep 24.

PMID:
30248673
17.

Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical Markers.

Daskalakis K, Kaltsas G, Öberg K, Tsolakis AV.

Neuroendocrinology. 2018;107(4):355-365. doi: 10.1159/000493944. Epub 2018 Sep 23.

PMID:
30244255
18.

Unmet Needs in Appendiceal Neuroendocrine Neoplasms.

Toumpanakis C, Fazio N, Tiensuu Janson E, Hörsch D, Pascher A, Reed N, O Apos Toole D, Nieveen van Dijkum E, Partelli S, Rinke A, Kos-Kudla B, Costa F, Pape UF, Grozinsky-Glasberg S, Scoazec JY; The ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):37-44. doi: 10.1159/000493894. Epub 2018 Sep 20.

PMID:
30235454
19.

Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need.

Ramage JK, Valle JW, Nieveen van Dijkum EJM, Sundin A, Pascher A, Couvelard A, Kloeppel G; the ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):45-53. doi: 10.1159/000493767. Epub 2018 Sep 16.

PMID:
30219817
20.

Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms.

Capdevila J, Bodei L, Davies P, Gorbounova V, Jensen RT, Knigge UP, Krejs GJ, Krenning E, O'Connor JM, Peeters M, Rindi G, Salazar R, Vullierme MP, Pavel ME; ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):18-25. doi: 10.1159/000493319. Epub 2018 Aug 28.

Supplemental Content

Loading ...
Support Center